//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,895.4523.35
Stock Analysis, IPO, Mutual Funds, Bonds & More

Lupin Ltd.

ET 500

Rank 2018
99
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:57 | 15-11-2019
  • BSE
    16:01 | 15-11-2019
742.25

Today's Change

3.90 (0.53%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

1,106,828

Open

739.85

Prev. Close

738.35

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)6.93
  • BV/share (₹)304.74
  • 52Wk L/H646.30/ 906.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed

Lupin Ltd Stock Price F & O Quotes

Equirus retains reduce on Lupin, target price Rs 684| Recos
Reduce
Hold Lupin, target Rs 861: Karvy Stock Broking| Recos
Hold
Sell Lupin, target Rs 800: Elara Capital| Recos
Sell
Buy Lupin, target Rs 820: Dr CK Narayan| Recos
Buy
Buy Lupin, target Rs 820: Kunal Bothra| Recos
Buy
Buy Lupin, target Rs 800: Dr CK Narayan| Recos
Buy
Buy Lupin, target Rs 985: HDFC Securities| Recos
Buy
Buy Lupin, target Rs 1,030: HDFC Securities| Recos
Buy
Sell Lupin, target Rs 783: Manas Jaiswal| Recos
Sell
Buy Lupin, target Rs 990: Jay Thakkar| Recos
Buy
Sell Lupin, target Rs 875: Dr CK Narayan| Recos
Sell
Buy Lupin, target Rs 905: Dr CK Narayan| Recos
Buy
Buy Lupin, target Rs 945: Jay Thakkar| Recos
Buy
Buy Lupin, target Rs 834: Kunal Bothra| Recos
Buy
Buy Lupin, target Rs 1190: HDFC Securities| Recos
Buy
Add Lupin Ltd. target Rs 815: ICICI Direct| Recos
Add
Buy Lupin, target Rs 815: Shrikant Chouhan| Recos
Buy
Buy Lupin, target Rs 960: Vikas Jain| Recos
Buy
Lupin Ltd.Extraordinary General Meeting (EGM) Of The Members Of Lupin Limited.| Announcement
Analyst Calls: Lupin, Info Edge, Sanofi, CIL| News
Lupin Ltd.Announcement under Regulation 30 (LODR)-Earnings Call Transcript| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Unaudited Standalone And Consolidated Financial Results Of The Company Along With Its Subsidiaries And A Joint Venture F...| Announcement
Lupin Ltd.Lupin Ltd reply to clarification sought by the exchange| Announcement
Lupin Ltd.Clarification sought from Lupin Ltd| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Allotment| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Lupin Ltd.Board Meeting Intimation for To Consider And Take On Record Unaudited Financial Results For The Quarter Ended September ...| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin gets EIR from USFDA for Nagpur facility| News
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Half Yearly Certificate As On September 30, 2019.| Announcement
Lupin Ltd.Half Yearly Certificate As On September 30, 2019.| Announcement
Lupin Ltd.Statement Of Investor Complaints For The Quarter Ended September 2019| Announcement
Lupin Ltd. share price up by 0.53% from its previous close of Rs 738.35. Lupin Ltd. stock last traded price is 742.25
Lupin Ltd. Share Price
Value
Today/Current/Last
742.25
Previous Day
738.35
What's your view on Lupin for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Lupin Ltd.

Lupin Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
4,296.90
-1.35
10.43
0.00
8123.35
Other Operating Income
62.75
0.32
4.36
0.00
174.16
Operating Profit
731.04
-15.02
33.00
-62.92
2640.87
Other Income
133.27
84.56
-42.23
-0.20
200.85
EBITDA
864.31
-7.31
10.76
-62.92
2640.87
Interest
86.46
0.98
17.12
0.00
116.00
Depreciation
321.47
1.38
21.09
0.00
473.28
Tax
34.30
-84.95
-80.16
-320.70
266.03
Net Profit
-127.07
NA
NA
-127.07
1106.80
EPS (₹)
-2.81
NA
NA
-12.25
66.68

Lupin Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
742.25
0.53
0.65
2.93
1.08
-13.06
-13.06
-13.06
410.25
3.65
-9.24
-9.90
-32.25
-47.44
-47.44
-47.44
234.50
0.11
-0.17
0.02
7.57
-34.73
-34.73
-34.73
257.25
1.00
-2.54
-1.17
10.67
-17.83
-17.83
-17.83
463.25
2.63
-1.82
3.74
-3.15
-10.77
-10.77
-10.77
2058.25
1.83
2.56
7.47
16.47
5.81
5.81
5.81
1782.15
0.60
-2.04
4.84
5.70
6.55
6.55
6.55
320.35
-0.65
-0.94
-1.60
4.93
10.68
10.68
10.68
2730.80
-0.12
-4.88
1.72
8.71
10.93
10.93
10.93
805.20
0.78
-1.75
6.12
-7.31
12.17
12.17
12.17
1747.70
5.51
1.73
3.22
14.09
14.17
14.17
14.17
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Lupin Ltd Risk Return Comparison

with peersNew

Lupin Ltd
Financial Comparison

with peers
Management Efficiency
Lupin Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
4.41
8.87
-99.01
47.57
Return on Assets (%)
2.36
5.79
-27.48
26.25
Return on capital Employed (%)
6.52
6.57
-130.86
23.01
Fixed Assets Turnover (x)
0.79
0.97
0.00
2.79
Profitability and Growth
Gross Profit Margin (%)
10.75
-8.77
-980.00
34.42
Operating Profit Margin(%)
17.24
0.38
-896.19
37.94
Net Profit margin (%)
3.62
2.06
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.41
1.65
0.08
9.50
Current Ratio (x)
2.18
2.40
0.21
9.50
Cash ratio (x)
0.17
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.48
0.27
0.00
1.77
Coverage Ratios
Cash flows to long term debt (x)
4.04
3.76
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Lupin Ltd Share Holding as on 30-06-2019

CategoryNo. of sharesPercentage
Promoters211,259,24846.68
ForeignInstitutions114,240,34425.24
GeneralPublic50,721,68311.21
NBanksMutualFunds32,048,5307.08
FinancialInstitutions27,424,9826.06
Others14,338,7393.17
ForeignPromoter1,286,3940.28
CentralGovt1,270,8320.28

MF Ownership Of Lupin Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Equity Direct-G
Portfolio as on 31-10-2019
Equity: Multi Cap
3094067
108.21%
0.98%
230.54
Kotak Standard Multicap Direct-G
Portfolio as on 31-10-2019
Equity: Multi Cap
3000000
0.00%
0.79%
223.53
Franklin India Equity Direct-G
Portfolio as on 31-10-2019
Equity: Multi Cap
2800000
0.00%
1.83%
208.63
HDFC Top 100 Direct-G
Portfolio as on 31-10-2019
Equity: Large Cap
2353718
131.34%
0.95%
175.38
L&T Tax Adv Direct-G
Portfolio as on 31-10-2019
Equity: ELSS
465800
0.00%
1.02%
34.71

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Lupin Ltd.

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 33604.24 Crore) operating in Pharmaceuticals sector.

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10657.32 Crore to Sales Value (93.84 % of Total Sales), Other Services which contributed Rs 374.24 Crore to Sales Value (3.29 % of Total Sales), Export Incentives which contributed Rs 250.66 Crore to Sales Value (2.20 % of Total Sales) and Other Operating Revenue which contributed Rs 74.10 Crore to Sales Value (0.65 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4296.90 Crore, down -1.35 % from last quarter Sales of Rs 4355.83 Crore and up 10.43 % from last year same quarter Sales of Rs 3890.93 Crore Company has reported net profit after tax of Rs -124.40 Crore in latest quarter.

The company’s top management includes Dr.K U Mada, Dr.Kamal K Sharma, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Deshbandhu Gupta, Mr.R A Shah, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Christine Mundkur, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditoRs As on 30-06-2019, the company has a total of 452,590,752 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors